{"filing":{"accession_number":"0001193125-26-369713","cik":"0001534133","ticker":"CALC","company_name":"CalciMedica, Inc.","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-27","primary_document":"d165361d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312526369713/d165361d8k.htm"},"events":[{"id":29948,"run_id":27449,"accession_number":"0001193125-26-369713","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"This disclosure describes a one-for-five reverse stock split and reduction in authorized shares, both approved by stockholders on August 19, 2026 and effectuated via Certificate of Amendment filed August 27, 2026. While a reverse stock split is a governance/capital structure matter (Item 5.03), it is material to investors as it affects share count, trading price, and equity compensation arrangements. The event is clearly governance-related but does not fit the specific named governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results), making governance_other the appropriate classification.","company_name":"CalciMedica, Inc.","ticker":"CALC","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":[{"id":32407,"accession_number":"0001193125-26-369713","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure describes a one-for-five reverse stock split and reduction in authorized shares, both approved by stockholders on August 19, 2026 and effectuated via Certificate of Amendment filed August 27, 2026. While a reverse stock split is a governance/capital structure matter (Item 5.03), it is material to investors as it affects share count, trading price, and equity compensation arrangements. The event is clearly governance-related but does not fit the specific named governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results), making governance_other the appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T13:08:46.092581+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32407,"accession_number":"0001193125-26-369713","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure describes a one-for-five reverse stock split and reduction in authorized shares, both approved by stockholders on August 19, 2026 and effectuated via Certificate of Amendment filed August 27, 2026. While a reverse stock split is a governance/capital structure matter (Item 5.03), it is material to investors as it affects share count, trading price, and equity compensation arrangements. The event is clearly governance-related but does not fit the specific named governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results), making governance_other the appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T13:08:46.092581+00:00","company_name":"CalciMedica, Inc.","ticker":"CALC","filing_date":"2026-08-27"}]}